BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wen MM, El-Salamouni NS, El-Refaie WM, Hazzah HA, Ali MM, Tosi G, Farid RM, Blanco-Prieto MJ, Billa N, Hanafy AS. Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. J Control Release 2017;245:95-107. [PMID: 27889394 DOI: 10.1016/j.jconrel.2016.11.025] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 La Barbera L, Mauri E, D’amelio M, Gori M. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives. Front Neurosci 2022;16:939855. [DOI: 10.3389/fnins.2022.939855] [Reference Citation Analysis]
2 Jiang Y, Jiang Y, Ding Z, Yu Q. Investigation of the “Nose-to-Brain” Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability. IJN 2022;Volume 17:3443-56. [DOI: 10.2147/ijn.s369978] [Reference Citation Analysis]
3 Marques MS, Marinho MAG, Vian CO, Horn AP. The action of curcumin against damage resulting from cerebral stroke: a systematic review. Pharmacol Res 2022;:106369. [PMID: 35914679 DOI: 10.1016/j.phrs.2022.106369] [Reference Citation Analysis]
4 Nascimento ALCS, Fernandes RP, Carvalho ACS, Frigieri I, Alves RC, Chorilli M. Insights for Alzheimer's disease pharmacotherapy and current clinical trials. Neurochem Int 2022;:105401. [PMID: 35842055 DOI: 10.1016/j.neuint.2022.105401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yasir M, Zafar A, Noorulla KM, Tura AJ, Sara UVS, Panjwani D, Khalid M, Haji MJ, Gobena WG, Gebissa T, Dalecha DD. Nose to brain delivery of donepezil through surface modified NLCs: Formulation development, optimization, and brain targeting study. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103631] [Reference Citation Analysis]
6 Wang P, Wang Y, Li P, Chen C, Ma S, Zhao L, He H, Yin T, Zhang Y, Tang X, Gou J. Oral delivery of polyester nanoparticles for brain-targeting: Challenges and opportunities. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.07.034] [Reference Citation Analysis]
7 Wu Y, Rakotoarisoa M, Angelov B, Deng Y, Angelova A. Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery. Nanomaterials 2022;12:2267. [DOI: 10.3390/nano12132267] [Reference Citation Analysis]
8 Pardridge WM. A Historical Review of Brain Drug Delivery. Pharmaceutics 2022;14:1283. [PMID: 35745855 DOI: 10.3390/pharmaceutics14061283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Lv H, Wang Y, Yang X, Ling G, Zhang P. Application of curcumin nanoformulations in Alzheimer's disease: prevention, diagnosis and treatment. Nutr Neurosci 2022;:1-16. [PMID: 35694842 DOI: 10.1080/1028415X.2022.2084550] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jan Z, Mollazadeh S, Abnous K, Taghdisi SM, Danesh A, Ramezani M, Alibolandi M. Targeted Delivery Platforms for the Treatment of Multiple Sclerosis. Mol Pharm 2022. [PMID: 35501974 DOI: 10.1021/acs.molpharmaceut.1c00892] [Reference Citation Analysis]
11 El Ganainy SO, Cijsouw T, Ali MA, Schoch S, Hanafy AS. Stereotaxic-assisted gene therapy in Alzheimer's and Parkinson's diseases: therapeutic potentials and clinical frontiers. Expert Rev Neurother 2022;:1-17. [PMID: 35319338 DOI: 10.1080/14737175.2022.2056446] [Reference Citation Analysis]
12 Salarpour S, Barani M, Pardakhty A, Khatami M, Pal Singh Chauhan N. The application of exosomes and Exosome-nanoparticle in treating brain disorders. Journal of Molecular Liquids 2022;350:118549. [DOI: 10.1016/j.molliq.2022.118549] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
13 Ortega-Pineda L, Sunyecz A, Salazar-Puerta AI, Rincon-Benavides MA, Alzate-Correa D, Anaparthi AL, Guilfoyle E, Mezache L, Struckman HL, Duarte-Sanmiguel S, Deng B, McComb DW, Dodd DJ, Lawrence WR, Moore J, Zhang J, Reátegui E, Veeraraghavan R, Nelson MT, Gallego-Perez D, Higuita-Castro N. Designer Extracellular Vesicles Modulate Pro-Neuronal Cell Responses and Improve Intracranial Retention. Adv Healthc Mater 2022;11:e2100805. [PMID: 35014204 DOI: 10.1002/adhm.202100805] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Jaragh-Alhadad LA, Falahati M. Tin oxide nanoparticles trigger the formation of amyloid β oligomers/protofibrils and underlying neurotoxicity as a marker of Alzheimer's diseases. Int J Biol Macromol 2022;204:154-60. [PMID: 35124024 DOI: 10.1016/j.ijbiomac.2022.01.190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rajamma SS, Krishnaswami V, Prabu SL, Kandasamy R. Geophila repens phytosome-loaded intranasal gel with improved nasal permeation for the effective treatment of Alzheimer's disease. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2021.103087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Küpeli Akkol E, Bardakcı H, Yücel Ç, Şeker Karatoprak G, Karpuz B, Khan H, Ghose J. A New Perspective on the Treatment of Alzheimer’s Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help? Oxidative Medicine and Cellular Longevity 2022;2022:1-23. [DOI: 10.1155/2022/6168199] [Reference Citation Analysis]
17 Ebrahimpour H, Toomari Y, Pooresmaeil M, Namazi H. Cluster of D-maltose clicked to β-cyclodextrin: preparation and its application as a biocompatible drug delivery nanovehicle. Soft Materials. [DOI: 10.1080/1539445x.2021.2019056] [Reference Citation Analysis]
18 Lei T, Yang Z, Xia X, Chen Y, Yang X, Xie R, Tong F, Wang X, Gao H. A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease. Acta Pharm Sin B 2021;11:4032-44. [PMID: 35024324 DOI: 10.1016/j.apsb.2021.04.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
19 Som Chaudhury S, Sinha K, Das Mukhopadhyay C. Intranasal route: The green corridor for Alzheimer's disease therapeutics. Journal of Drug Delivery Science and Technology 2021;66:102791. [DOI: 10.1016/j.jddst.2021.102791] [Reference Citation Analysis]
20 Shome S, Talukdar AD, Upadhyaya H. Antibacterial activity of curcumin and its essential nanoformulations against some clinically important bacterial pathogens: A comprehensive review. Biotechnol Appl Biochem 2021. [PMID: 34826356 DOI: 10.1002/bab.2289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Chen T, Yuan M, Tao Y, Ren X, Li S. Engineering of Self-assembly Polymers Encapsulated with Dual Anticancer Drugs for the Treatment of Endometrial Cancer. J Clust Sci. [DOI: 10.1007/s10876-021-02175-5] [Reference Citation Analysis]
22 Abbas H, Gad HA, Khattab MA, Mansour M. The Tragedy of Alzheimer's Disease: Towards Better Management via Resveratrol-Loaded Oral Bilosomes. Pharmaceutics 2021;13:1635. [PMID: 34683928 DOI: 10.3390/pharmaceutics13101635] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Zong Y, Xiao W, Wang B, Zhu G, Chen J. Preparation of Nanomolecular Probe and Its Effect on the Degradation of Amyloid β -Protein in Alzheimer’s Disease. sci adv mater 2021;13:1899-906. [DOI: 10.1166/sam.2021.4122] [Reference Citation Analysis]
24 Tripathi S, Gupta U, Ujjwal RR, Yadav AK. Nano-lipidic formulation and therapeutic strategies for Alzheimer's disease via intranasal route. J Microencapsul 2021;38:572-93. [PMID: 34591731 DOI: 10.1080/02652048.2021.1986585] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-kubati SS. Recent progress in nanocarriers for direct nose to brain drug delivery. Journal of Drug Delivery Science and Technology 2021;64:102642. [DOI: 10.1016/j.jddst.2021.102642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Zeng H, Xu L, Zou Y, Wang S. Romidepsin and metformin nanomaterials delivery on streptozocin for the treatment of Alzheimer's disease in animal model. Biomed Pharmacother 2021;141:111864. [PMID: 34323698 DOI: 10.1016/j.biopha.2021.111864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ling TS, Chandrasegaran S, Xuan LZ, Suan TL, Elaine E, Nathan DV, Chai YH, Gunasekaran B, Salvamani S. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease. Biomed Res Int 2021;2021:5550938. [PMID: 34285915 DOI: 10.1155/2021/5550938] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Kandil LS, Farid RM, ElGamal SS, Hanafy AS. Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect. Drug Dev Ind Pharm 2021;47:735-40. [PMID: 34032549 DOI: 10.1080/03639045.2021.1934861] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Mota IFL, de Lima LS, Santana BM, Gobbo GAM, Bicca JVML, Azevedo JRM, Veras LG, Taveira RAA, Pinheiro GB, Mortari MR. Alzheimer's Disease: Innovative Therapeutic Approaches Based on Peptides and Nanoparticles. Neuroscientist 2021;:10738584211016409. [PMID: 34018874 DOI: 10.1177/10738584211016409] [Reference Citation Analysis]
30 K C S, Kakoty V, Krishna KV, Dubey SK, Chitkara D, Taliyan R. Neuroprotective Efficacy of Co-Encapsulated Rosiglitazone and Vorinostat Nanoparticle on Streptozotocin Induced Mice Model of Alzheimer Disease. ACS Chem Neurosci 2021;12:1528-41. [PMID: 33860663 DOI: 10.1021/acschemneuro.1c00022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Sivandzade F, Cucullo L. Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview. Int J Mol Sci 2021;22:2153. [PMID: 33671500 DOI: 10.3390/ijms22042153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
32 Narayanamurthy R, Yang JJ, Yager JY, Unsworth LD. Drug delivery platforms for neonatal brain injury. J Control Release 2021;330:765-87. [PMID: 33417984 DOI: 10.1016/j.jconrel.2020.12.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Altinoglu G, Adali T. Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems. Curr Drug Targets 2020;21:628-46. [PMID: 31744447 DOI: 10.2174/1389450120666191118123151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
34 Froelich A, Osmałek T, Jadach B, Puri V, Michniak-Kohn B. Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics 2021;13:201. [PMID: 33540856 DOI: 10.3390/pharmaceutics13020201] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
35 Kaabipour S, Hemmati S. A review on the green and sustainable synthesis of silver nanoparticles and one-dimensional silver nanostructures. Beilstein J Nanotechnol 2021;12:102-36. [PMID: 33564607 DOI: 10.3762/bjnano.12.9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
36 Ou G, Chen W, Yang M, Li Q, Zhang Y, Wan D, Du L, Ma B. Preventive effect of nasal Timosaponin BII-loaded temperature-/ion-sensitive in situ hydrogels on Alzheimer’s disease. Journal of Traditional Chinese Medical Sciences 2021;8:59-64. [DOI: 10.1016/j.jtcms.2021.01.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Agarwal M, Alam MR, Haider MK, Malik MZ, Kim DK. Alzheimer's Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology. Nanomaterials (Basel) 2020;11:E59. [PMID: 33383712 DOI: 10.3390/nano11010059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
38 Rabiee N, Ahmadi S, Afshari R, Khalaji S, Rabiee M, Bagherzadeh M, Fatahi Y, Dinarvand R, Tahriri M, Tayebi L, Hamblin MR, Webster TJ. Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease. Adv Therap 2021;4:2000076. [DOI: 10.1002/adtp.202000076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
39 Bahadur S, Sachan N, Harwansh RK, Deshmukh R. Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery. Curr Pharm Des 2020;26:1331-44. [PMID: 32160843 DOI: 10.2174/1381612826666200311131658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
40 Akhtar A, Andleeb A, Waris TS, Bazzar M, Moradi AR, Awan NR, Yar M. Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics. J Control Release 2021;330:1152-67. [PMID: 33197487 DOI: 10.1016/j.jconrel.2020.11.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
41 Zorkina Y, Abramova O, Ushakova V, Morozova A, Zubkov E, Valikhov M, Melnikov P, Majouga A, Chekhonin V. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 2020;25:E5294. [PMID: 33202839 DOI: 10.3390/molecules25225294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
42 Tatiparti K, Sau S, Rauf MA, Iyer AK. Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease. Drug Discov Today 2020;25:2110-29. [PMID: 33011341 DOI: 10.1016/j.drudis.2020.09.025] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Moreira NCDS, Lima JEBF, Chierrito TPC, Carvalho I, Sakamoto-Hojo ET. Novel Hybrid Acetylcholinesterase Inhibitors Induce Differentiation and Neuritogenesis in Neuronal Cells in vitro Through Activation of the AKT Pathway. J Alzheimers Dis 2020;78:353-70. [PMID: 32986667 DOI: 10.3233/JAD-200425] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Hanafy AS, Schoch S, Lamprecht A. CRISPR/Cas9 Delivery Potentials in Alzheimer's Disease Management: A Mini Review. Pharmaceutics 2020;12:E801. [PMID: 32854251 DOI: 10.3390/pharmaceutics12090801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
45 Kassem LM, Ibrahim NA, Farhana SA. Nanoparticle Therapy Is a Promising Approach in the Management and Prevention of Many Diseases: Does It Help in Curing Alzheimer Disease? Journal of Nanotechnology 2020;2020:1-8. [DOI: 10.1155/2020/8147080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Askarizadeh A, Barreto GE, Henney NC, Majeed M, Sahebkar A. Neuroprotection by curcumin: A review on brain delivery strategies. International Journal of Pharmaceutics 2020;585:119476. [DOI: 10.1016/j.ijpharm.2020.119476] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
47 Gorain B, Rajeswary DC, Pandey M, Kesharwani P, Kumbhar SA, Choudhury H. Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition. CPD 2020;26:2233-46. [DOI: 10.2174/1381612826666200313125613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
48 Zaki AG, El-Sayed ER, Abd Elkodous M, El-Sayyad GS. Microbial acetylcholinesterase inhibitors for Alzheimer's therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery. Appl Microbiol Biotechnol 2020;104:4717-35. [PMID: 32285176 DOI: 10.1007/s00253-020-10560-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
49 Teixeira MI, Lopes CM, Amaral MH, Costa PC. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Eur J Pharm Biopharm 2020;149:192-217. [PMID: 31982574 DOI: 10.1016/j.ejpb.2020.01.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
50 Qian C, Yuan C, Li C, Liu H, Wang X. Multifunctional nano-enabled delivery systems in Alzheimer's disease management. Biomater Sci 2020;8:5538-54. [DOI: 10.1039/d0bm00756k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
51 Zhao J, Du YH, Ding XT, Wang XH, Men GZ. Alteration of functional connectivity in patients with Alzheimer's disease revealed by resting-state functional magnetic resonance imaging. Neural Regen Res 2020;15:285-92. [PMID: 31552901 DOI: 10.4103/1673-5374.265566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
52 Tosi G, Duskey JT, Kreuter J. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opin Drug Deliv 2020;17:23-32. [PMID: 31774000 DOI: 10.1080/17425247.2020.1698544] [Cited by in Crossref: 30] [Cited by in F6Publishing: 48] [Article Influence: 10.0] [Reference Citation Analysis]
53 Sathya S, Shanmuganathan B, Balasubramaniam B, Balamurugan K, Devi KP. Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer's related genes and neuronal apoptosis against amyloid-β induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans. Food Chem Toxicol 2020;136:110962. [PMID: 31734340 DOI: 10.1016/j.fct.2019.110962] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
54 Nag OK, Delehanty JB. Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery. Pharmaceutics 2019;11:E543. [PMID: 31635367 DOI: 10.3390/pharmaceutics11100543] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
55 Fatima S, Mohammad T, Jairajpuri DS, Rehman MT, Hussain A, Samim M, Ahmad FJ, Alajmi MF, Hassan MI. Identification and evaluation of glutathione conjugate gamma-l-glutamyl-l-cysteine for improved drug delivery to the brain. J Biomol Struct Dyn 2020;38:3610-20. [PMID: 31496427 DOI: 10.1080/07391102.2019.1664937] [Cited by in Crossref: 18] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
56 Krishna KV, Wadhwa G, Alexander A, Kanojia N, Saha RN, Kukreti R, Singhvi G, Dubey SK. Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery. ACS Chem Neurosci 2019;10:4124-35. [PMID: 31418556 DOI: 10.1021/acschemneuro.9b00343] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
57 dos Santos Rodrigues B, Kanekiyo T, Singh J. ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles. Pharm Res 2019;36. [DOI: 10.1007/s11095-019-2691-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
58 Raikwar SP, Thangavel R, Dubova I, Ahmed ME, Selvakumar PG, Kempuraj D, Zaheer S, Iyer S, Zaheer A. Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet? J Alzheimers Dis 2018;65:321-44. [PMID: 30040732 DOI: 10.3233/JAD-180422] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
59 Patel A, Surti N, Mahajan A. Intranasal drug delivery: Novel delivery route for effective management of neurological disorders. Journal of Drug Delivery Science and Technology 2019;52:130-7. [DOI: 10.1016/j.jddst.2019.04.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
60 Vissers C, Ming GL, Song H. Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders. Adv Drug Deliv Rev 2019;148:239-51. [PMID: 30797953 DOI: 10.1016/j.addr.2019.02.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 15.3] [Reference Citation Analysis]
61 Wechsler ME, Ramirez JEV, Peppas NA. 110th Anniversary: Nanoparticle mediated drug delivery for the treatment of Alzheimer's disease: Crossing the blood-brain barrier. Ind Eng Chem Res 2019;58:15079-87. [PMID: 32982041 DOI: 10.1021/acs.iecr.9b02196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
62 Mendes I, Ruela A, Carvalho F, Freitas J, Bonfilio R, Pereira G. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids and Surfaces B: Biointerfaces 2019;177:274-81. [DOI: 10.1016/j.colsurfb.2019.02.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
63 Riediker M, Zink D, Kreyling W, Oberdörster G, Elder A, Graham U, Lynch I, Duschl A, Ichihara G, Ichihara S, Kobayashi T, Hisanaga N, Umezawa M, Cheng TJ, Handy R, Gulumian M, Tinkle S, Cassee F. Particle toxicology and health - where are we? Part Fibre Toxicol 2019;16:19. [PMID: 31014371 DOI: 10.1186/s12989-019-0302-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 70] [Article Influence: 20.3] [Reference Citation Analysis]
64 Mufamadi MS, Kumar P, du Toit LC, Choonara YE, Obulapuram PK, Modi G, Naidoo D, Iyuke SE, Pillay V. Liposome-embedded, polymeric scaffold for extended delivery of galantamine. Journal of Drug Delivery Science and Technology 2019;50:255-65. [DOI: 10.1016/j.jddst.2019.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
65 Espinoza LC, Silva-Abreu M, Clares B, Rodríguez-Lagunas MJ, Halbaut L, Cañas MA, Calpena AC. Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil. Pharmaceutics 2019;11:E64. [PMID: 30717264 DOI: 10.3390/pharmaceutics11020064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
66 Roumiani ME, Dorosti N. Sonochemical synthesis of a nanodandelion tin(IV) complex with carbacylamidophosphate ligand as anti-Alzheimer agent: Molecular docking study. Ultrason Sonochem 2019;55:207-16. [PMID: 30745233 DOI: 10.1016/j.ultsonch.2019.01.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
67 Gheibi Hayat SM, Darroudi M. Nanovaccine: A novel approach in immunization. J Cell Physiol 2019;234:12530-6. [PMID: 30633361 DOI: 10.1002/jcp.28120] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
68 Keçili R, Büyüktiryaki S, Hussain CM. Advancement in bioanalytical science through nanotechnology: Past, present and future. TrAC Trends in Analytical Chemistry 2019;110:259-76. [DOI: 10.1016/j.trac.2018.11.012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 24] [Article Influence: 20.7] [Reference Citation Analysis]
69 Langasco R, Fancello S, Rassu G, Cossu M, Cavalli R, Galleri G, Giunchedi P, Migheli R, Gavini E. Increasing protective activity of genistein by loading into transfersomes: A new potential adjuvant in the oxidative stress-related neurodegenerative diseases? Phytomedicine 2019;52:23-31. [DOI: 10.1016/j.phymed.2018.09.207] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
70 Mirgorodskaya AB, Kushnazarova RA, Nikitina AV, Semina II, Nizameev IR, Kadirov MK, Khutoryanskiy VV, Zakharova LY, Sinyashin OG. Polyelectrolyte nanocontainers: Controlled binding and release of indomethacin. Journal of Molecular Liquids 2018;272:982-9. [DOI: 10.1016/j.molliq.2018.10.115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
71 de la Torre C, Ceña V. The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer's Disease Therapeutics and Diagnostics. Pharmaceutics 2018;10:E190. [PMID: 30336640 DOI: 10.3390/pharmaceutics10040190] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
72 Md S, Gan SY, Haw YH, Ho CL, Wong S, Choudhury H. In vitro neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation. International Journal of Biological Macromolecules 2018;118:1211-9. [DOI: 10.1016/j.ijbiomac.2018.06.190] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 8.3] [Reference Citation Analysis]
73 Siddiqi KS, Husen A, Sohrab SS, Yassin MO. Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management. Nanoscale Res Lett 2018;13:231. [PMID: 30097809 DOI: 10.1186/s11671-018-2638-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
74 Park K. The drug delivery field needs a well-diversified technology portfolio. J Control Release 2017;245:177. [PMID: 28065323 DOI: 10.1016/j.jconrel.2016.12.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
75 Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. Journal of Controlled Release 2018;281:139-77. [DOI: 10.1016/j.jconrel.2018.05.011] [Cited by in Crossref: 163] [Cited by in F6Publishing: 203] [Article Influence: 40.8] [Reference Citation Analysis]
76 Rout GK, Shin HS, Gouda S, Sahoo S, Das G, Fraceto LF, Patra JK. Current advances in nanocarriers for biomedical research and their applications. Artif Cells Nanomed Biotechnol 2018;46:1053-62. [PMID: 29879850 DOI: 10.1080/21691401.2018.1478843] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
77 Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Hamano N, Li S, Chougule M, Shoyele SA, Gupta U, Ajazuddin, Alexander A. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opinion on Drug Delivery 2018;15:589-617. [DOI: 10.1080/17425247.2018.1471058] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 9.5] [Reference Citation Analysis]
78 Mohamed HE, Asker ME, Younis NN, Shaheen MA, Eissa RG. Modulation of brain insulin signaling in Alzheimer’s disease: New insight on the protective role of green coffee bean extract. Nutritional Neuroscience 2020;23:27-36. [DOI: 10.1080/1028415x.2018.1468535] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
79 Shalaby TI, El-Refaie WM. Bioadhesive Chitosan-Coated Cationic Nanoliposomes With Improved Insulin Encapsulation and Prolonged Oral Hypoglycemic Effect in Diabetic Mice. J Pharm Sci 2018;107:2136-43. [PMID: 29689252 DOI: 10.1016/j.xphs.2018.04.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
80 Silva-Abreu M, Espinoza LC, Halbaut L, Espina M, García ML, Calpena AC. Comparative Study of Ex Vivo Transmucosal Permeation of Pioglitazone Nanoparticles for the Treatment of Alzheimer's Disease. Polymers (Basel) 2018;10:E316. [PMID: 30966351 DOI: 10.3390/polym10030316] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
81 Chen Q, Du Y, Zhang K, Liang Z, Li J, Yu H, Ren R, Feng J, Jin Z, Li F, Sun J, Zhou M, He Q, Sun X, Zhang H, Tian M, Ling D. Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer's Disease. ACS Nano 2018;12:1321-38. [PMID: 29364648 DOI: 10.1021/acsnano.7b07625] [Cited by in Crossref: 126] [Cited by in F6Publishing: 123] [Article Influence: 31.5] [Reference Citation Analysis]
82 Maysinger D, Ji J, Moquin A, Hossain S, Hancock MA, Zhang I, Chang PKY, Rigby M, Anthonisen M, Grütter P, Breitner J, McKinney RA, Reimann S, Haag R, Multhaup G. Dendritic Polyglycerol Sulfates in the Prevention of Synaptic Loss and Mechanism of Action on Glia. ACS Chem Neurosci 2018;9:260-71. [PMID: 29078046 DOI: 10.1021/acschemneuro.7b00301] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
83 Md S, Bhattmisra SK, Zeeshan F, Shahzad N, Mujtaba MA, Srikanth Meka V, Radhakrishnan A, Kesharwani P, Baboota S, Ali J. Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 2018;43:295-310. [DOI: 10.1016/j.jddst.2017.09.022] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
84 El-mezayen NS, El-hadidy WF, El-refaie WM, Shalaby T, Khattab MM, El-khatib AS. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis. Journal of Controlled Release 2017;266:226-37. [DOI: 10.1016/j.jconrel.2017.09.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
85 Huang N, Lu S, Liu XG, Zhu J, Wang YJ, Liu RT. PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice. Oncotarget 2017;8:81001-13. [PMID: 29113362 DOI: 10.18632/oncotarget.20944] [Cited by in Crossref: 46] [Cited by in F6Publishing: 59] [Article Influence: 9.2] [Reference Citation Analysis]
86 Baldissera MD, Souza CF, Boligon AA, Grando TH, DE Sá MF, DA Silva AS, Stefani LM, Baldisserotto B, Monteiro SG. Solving the challenge of the blood-brain barrier to treat infections caused by Trypanosoma evansi: evaluation of nerolidol-loaded nanospheres in mice. Parasitology 2017;144:1543-50. [PMID: 28641606 DOI: 10.1017/S003118201700110X] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
87 Pashirova TN, Zueva IV, Petrov KA, Babaev VM, Lukashenko SS, Rizvanov IK, Souto EB, Nikolsky EE, Zakharova LY, Masson P, Sinyashin OG. Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity. ACS Appl Mater Interfaces 2017;9:16922-32. [DOI: 10.1021/acsami.7b04163] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
88 Tosi U, Marnell CS, Chang R, Cho WC, Ting R, Maachani UB, Souweidane MM. Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors. Int J Mol Sci 2017;18:E351. [PMID: 28208698 DOI: 10.3390/ijms18020351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
89 Guo M, Li Y, Lin Z, Zhao M, Xiao M, Wang C, Xu T, Xia Y, Zhu B. Surface decoration of selenium nanoparticles with curcumin induced HepG2 cell apoptosis through ROS mediated p53 and AKT signaling pathways. RSC Adv 2017;7:52456-64. [DOI: 10.1039/c7ra08796a] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]